Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Director/PDMR Shareholding

4 Dec 2024 09:40

RNS Number : 7843O
Duke Capital Limited
04 December 2024
Β 

4 December 2024

Β 

Β 

Β 

Duke Capital Limited

Β 

("Duke Capital", "Duke" or the "Company")

Β 

Director / PDMR Dealings

Β 

Further to its announcement on 15 November 2024, and following admission of the Placing Shares and Subscription Shares to trading on AIM this morning, the Company announces that the following Directors and/or their persons closely associated ("PCAs") have acquired the following New Shares issued in connection with the Fundraising at the Issue Price:

Β 

Director/PCA/PDMR

Number of New Shares subscribed

Neil Johnson

363,636

Nigel Birrell

363,636

Arlington Group Asset Management LimitedΒ (1)

1,818,181

Oryx Consulting Limited (2)

363,636

(1) Arlington Group Asset Management Limited, an entity in which Charlie Cannon Brookes, Executive Director, has a 50 per cent. interest, and which is a PCA of Mr Cannon Brookes

(2) Oryx Consulting Limited is a PCA of Maree Wilms, Non-Executive Director of Duke Capital

Capitalised terms used in this announcement have the meaning given to them in the Placing and Retail Offer announcement dated 14 November 2024, unless otherwise defined in this announcement.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Neil Johnson

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Initial

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Duke Capital Limited

b)

Β 

LEI

213800GUTKPSJ39SER44

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β Ordinary shares of nil par value

Β 

ISIN: GG00BYZSSY63

b)

Β 

Nature of the transaction

Acquisition of shares pursuant to the Subscription

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

27.5 pence per share

363,636

d)

Β 

Aggregated information

- Aggregated volume

- Price

N/A

e)

Β 

Date of the transaction

Β 

4 December 2024

f)

Β 

Place of the transaction

Β 

London Stock Exchange

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Nigel Birrell

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Non-Executive Chairman

b)

Β 

Initial notification /Amendment

Initial

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Duke Capital Limited

b)

Β 

LEI

213800GUTKPSJ39SER44

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β Ordinary shares of nil par value

Β 

ISIN: GG00BYZSSY63

b)

Β 

Nature of the transaction

Acquisition of shares pursuant to the Subscription

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

27.5 pence per share

363,636

d)

Β 

Aggregated information

- Aggregated volume

- Price

N/A

e)

Β 

Date of the transaction

Β 

4 December 2024

f)

Β 

Place of the transaction

Β 

London Stock Exchange

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Arlington Group Asset Management LimitedΒ 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

PCA of Charlie Cannon Brookes, Executive Director and Chief Investment Officer

b)

Β 

Initial notification /Amendment

Initial

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Duke Capital Limited

b)

Β 

LEI

213800GUTKPSJ39SER44

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β Ordinary shares of nil par value

Β 

ISIN: GG00BYZSSY63

b)

Β 

Nature of the transaction

Acquisition of shares pursuant to the Placing

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

27.5 pence per share

1,818,181

d)

Β 

Aggregated information

- Aggregated volume

- Price

N/A

e)

Β 

Date of the transaction

Β 

4 December 2024

f)

Β 

Place of the transaction

Β 

London Stock Exchange

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Oryx Consulting Limited

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

PCA of Maree Wilms, Non-Executive Director

b)

Β 

Initial notification /Amendment

Initial

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Duke Capital Limited

b)

Β 

LEI

213800GUTKPSJ39SER44

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β Ordinary shares of nil par value

Β 

ISIN: GG00BYZSSY63

b)

Β 

Nature of the transaction

Acquisition of shares pursuant to the Subscription

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

27.5 pence per share

363,636

d)

Β 

Aggregated information

- Aggregated volume

- Price

N/A

e)

Β 

Date of the transaction

Β 

4 December 2024

f)

Β 

Place of the transaction

Β 

London Stock Exchange

***ENDS***

Β 

Β 

Β 

For further information, please visitΒ https://dukecapital.com/Β or contact:

Β 

Duke Capital Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

Β 

+44 (0) 1481 231 816

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Stephen Keys / Callum Davidson / Michael JohnsonΒ 

+44 (0) 207 220 0500

Β 

Canaccord Genuity Limited

(Joint Broker)

Β 

Adam James / Harry Rees / Sam Lucas

+44 (0) 207 523 8000

SEC Newgate (Financial Communications)

Elisabeth Cowell / Alice Cho

+ +44 (0) 20 3757 6882 dukecapital@secnewgate.co.uk

Β 

Β 

About Duke Capital

Β 

Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.

Β 

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.

Β 

Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. It's three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits. Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUPGCWPUPCUBC
Date   Source Headline
28th May 20267:00 amRNSNotice of Results & Investor Presentation
31st Mar 20267:00 amRNSTrading and Operational Update
19th Mar 20267:00 amRNSInterim Dividend and Dividend Declaration
26th Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
18th Dec 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Dec 20257:00 amRNSInterim Financial Results
17th Oct 20257:00 amRNSFollow-On Investment into Step Investments Limited
1st Oct 20257:00 amRNSFollow-On Investment into Integrum Group Holdings
29th Sep 20257:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Aug 202511:17 amRNSResult of Annual General Meeting
1st Aug 20258:08 amRNSDirector/PDMR Dealings
11th Jul 20257:00 amRNSAnnual Report & Notice of Annual General Meeting
25th Jun 20257:00 amRNSFinal Results for the year ended 31 March 2025
19th Jun 20257:00 amRNSInterim Dividend and Dividend Declaration
2nd Jun 20257:00 amRNSFollow-On Investment into Existing Capital Partner
27th May 20257:00 amRNSNotice of Results & Investor Presentation
2nd Apr 20257:00 amRNSFollow-On Investment into Existing Capital Partner
31st Mar 20257:00 amRNSTrading and Operational Update
20th Mar 20257:00 amRNSInterim Dividend and Dividend Declaration
19th Feb 20257:00 amRNSFollow-On Investment into BPVA (Ireland) Limited
30th Dec 20247:00 amRNSTrading and Operational Update
17th Dec 202412:50 pmRNSInterim Dividend and Dividend Declaration
16th Dec 20247:00 amRNSInterim Results for the six months ended 30 Sep 24
4th Dec 20249:40 amRNSDirector/PDMR Shareholding
3rd Dec 202411:34 amRNSResult of General Meeting and Issue of Equity
22nd Nov 20243:38 pmRNSResult of Retail Offer and Broker Option
15th Nov 20247:00 amRNSResult of Placing
14th Nov 20245:02 pmRNSRetail Offer to raise up to £3.0 million
14th Nov 20245:01 pmRNSIssue of Equity
30th Sep 20247:00 amRNSTrading and Operational Update
19th Sep 20247:00 amRNSInterim Dividend and Dividend Declaration
3rd Sep 20247:00 amRNSFollow-On Investment into United Glass Group
1st Aug 20243:16 pmRNSDirector/PDMR Dealings
1st Aug 202411:40 amRNSResult of Annual General Meeting
22nd Jul 20247:00 amRNSFollow-On Investment into Step Investments Limited
15th Jul 20247:00 amRNSAnnual Report & Notice of Annual General Meeting
27th Jun 20247:00 amRNSFinal Results for the year ended 31 March 2024
20th Jun 202411:50 amRNSInterim Dividend and Dividend Declaration
3rd Jun 20247:00 amRNSNotice of Results
17th May 202411:45 amEQSHardman & Co Q&A on Duke Capital (DUKE) | Generating investor returns by uniquely meeting customer needs
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.